We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+13.63%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$27.1B
AUM Growth
+$1.76B
Cap. Flow
-$1.21B
Cap. Flow %
-4.45%
Top 10 Hldgs %
42.04%
Holding
292
New
14
Increased
41
Reduced
114
Closed
11

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$56.5M
2
RTX icon
RTX Corp
RTX
+$44.9M
3
LLY icon
Eli Lilly
LLY
+$39.2M
4
MA icon
Mastercard
MA
+$24.4M
5
UNH icon
UnitedHealth
UNH
+$14M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$283M
2
TROW icon
T. Rowe Price
TROW
+$142M
3
AAPL icon
Apple
AAPL
+$73.9M
4
PM icon
Philip Morris
PM
+$72.2M
5
CVX icon
Chevron
CVX
+$62.4M

Sector Composition

Rank Sector Weight
1 Technology 19.65%
2 Consumer Staples 19.62%
3 Financials 18.7%
4 Energy 13.49%
5 Healthcare 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOVA
101
DELISTED
Sunnova Energy
NOVA
$6.38M 0.02%
354,161
DUK icon
102
Duke Energy
DUK
$96.9B
$5.97M 0.02%
57,981
-11,250
-16% -$1.08M
COST icon
103
Costco
COST
$423B
$5.86M 0.02%
12,834
AMT icon
104
American Tower
AMT
$80.6B
$5.74M 0.02%
27,105
+75
+0.3% +$15.6K
HON icon
105
Honeywell
HON
$78.2B
$5.62M 0.02%
27,827
+34
+0.1% +$6.5K
CARR icon
106
Carrier Global
CARR
$52.1B
$5.2M 0.02%
126,070
-11,380
-8% -$462K
GOOGL icon
107
Alphabet (Google) Class A
GOOGL
$4.57T
$5.16M 0.02%
58,520
-420
-0.7% -$39.9K
SCI icon
108
Service Corp International
SCI
$11.7B
$5.14M 0.02%
74,325
OGN icon
109
Organon & Co
OGN
$3.56B
$5.05M 0.02%
180,725
-431,548
-70% -$11M
FMX icon
110
Fomento Económico Mexicano
FMX
$42.8B
$4.41M 0.02%
56,435
-150
-0.3% -$11K
CME icon
111
CME Group
CME
$95.7B
$4.38M 0.02%
26,023
+6,760
+35% +$1.17M
MDT icon
112
Medtronic
MDT
$111B
$4.31M 0.02%
55,405
-540
-1% -$43.8K
OVV icon
113
Ovintiv
OVV
$17.1B
$4.14M 0.02%
81,733
ACN icon
114
Accenture
ACN
$101B
$3.98M 0.01%
14,909
-465
-3% -$129K
ITW icon
115
Illinois Tool Works
ITW
$83B
$3.93M 0.01%
17,854
GILD icon
116
Gilead Sciences
GILD
$163B
$3.84M 0.01%
44,785
-200
-0.4% -$15.8K
AVGO icon
117
Broadcom
AVGO
$1.87T
$3.81M 0.01%
68,090
CL icon
118
Colgate-Palmolive
CL
$71.6B
$3.72M 0.01%
47,259
-3,580
-7% -$268K
CPT icon
119
Camden Property Trust
CPT
$11B
$3.5M 0.01%
31,260
-800
-2% -$91.6K
ORCL icon
120
Oracle
ORCL
$409B
$3.45M 0.01%
42,261
-30
-0.1% -$2.28K
OKE icon
121
Oneok
OKE
$55.6B
$3.3M 0.01%
50,177
SLB icon
122
SLB Ltd
SLB
$73.2B
$3.25M 0.01%
60,566
+286
+0.5% +$14.2K
CNS icon
123
Cohen & Steers
CNS
$4.35B
$3.23M 0.01%
50,000
-50,000
-50% -$3.14M
SYY icon
124
Sysco
SYY
$40.7B
$3.11M 0.01%
40,619
BTI icon
125
British American Tobacco
BTI
$128B
$3.09M 0.01%
77,250

Similar funds

Fayez Sarofim & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Fayez Sarofim & Co held 292 positions worth $27.1B, up 6.9% from $25.3B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Fayez Sarofim & Co withdrew a net $1.21B in Q4 2022, closing 11 positions and reducing 114 holdings. Its most notable exit was Artisan Partners, an estimated $16.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Fayez Sarofim & Co opened a new position in AstraZeneca worth $1.67M.

  • Fayez Sarofim & Co's largest Q4 2022 buy was AstraZeneca: 12,348 shares worth $1.67M.
  • Fayez Sarofim & Co added most to Visa in Q4 2022, an estimated $56.5M increase.
  • Fayez Sarofim & Co's biggest Q4 2022 reduction was Meta Platforms (Facebook), cutting an estimated $283M.
  • Fayez Sarofim & Co fully exited Artisan Partners in Q4 2022, selling an estimated $16.2M.
  • Fayez Sarofim & Co's ten largest holdings make up 42% of its $27.1B portfolio in Q4 2022.
  • Fayez Sarofim & Co opened 14 new positions and closed 11 in Q4 2022.
  • Fayez Sarofim & Co's portfolio value rose 6.9% quarter-over-quarter to $27.1B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2022, filed 13 Feb 2023.